The global structural heart imaging market size is expected to reach USD 13.12 billion by 2030, registering a CAGR of 5.92%, according to a new report by Grand View Research, Inc. Global increase in incidence of Structural Heart Diseases (SHDs), growing awareness about diseases, and technological advancements in imaging modalities are anticipated to drive the market during the forecast period.
Furthermore, clearer high-quality images are necessary for management of patients suffering from SHDs. Hence, availability of technologically advanced devices and increase in their adoption are likely to boost the market in the coming years. Echocardiogram, Magnetic Resonance Imaging (MRI) and CT are the most widely used modalities for SHI.
Echocardiogram accounted for the maximum market share in 2023 and is estimated to maintain its dominance during the forecast period. This can be attributed to the adoption of echo test as a first-line imaging technique, low cost as compared to CT & MRI, and its superiority in visualization of intracardiac structures.
MRI segment is expected to witness the fastest growth in the coming years due to technological advancements, as well as the ability of MRI to provide accurate & reproducible quantification of ventricular function and image the entire body.
Request a free sample copy or view report summary: Structural Heart Imaging Market Report
The angiogram accounted as the most dominant segment with a share of 36.75% in 2024. During angiography, the devices detect heart failures and other cardiovascular diseases.
The Transcatheter Aortic Valve Replacement (TAVR) segment dominated by capturing the market share of 22.58% in 2024, driven by its widespread adoption as a minimally invasive alternative to open-heart surgery for treating aortic stenosis.
Geographically, in 2024, North America accounted the largest share and is expected to maintain its dominance during forecast period due to availability of technologically advanced devices, high healthcare expenditure, and favorable reimbursement policies for imaging
Asia Pacific is likely to witness lucrative growth in the coming years owing to growing investments by players in the region and increase in well-equipped & sophisticated hospitals. These factors are expected to result in rise in demand for advanced procedures for structural heart diseases
Grand View Research has segmented the global structural heart imaging market report based on modality, procedure, application, end use, and region:
Structural Heart Imaging Modality Outlook (Revenue, USD Million, 2018 - 2030)
Echocardiogram
Angiogram
CT
MRI
Nuclear Imaging
Other Modalities
Structural Heart Imaging Procedure Outlook (Revenue, USD Million, 2018 - 2030)
Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Transcatheter Mitral Valve Repair (TMVR)
Left Atrial Appendage Closure (LAAC)
Tricuspid Valve Replacement and Repair
Paravalvular Leak Detection and Repair
Annuloplasty
Valvuloplasty
Other Structural Heart Procedures
Structural Heart Imaging Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostic Imaging
Interventional Cardiology
Structural Heart Imaging End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Ambulatory Surgical Centers
Diagnostic Imaging Centers
Other End Use
Structural Heart Imaging Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Structural Heart Imaging Market
Siemens Healthineers
GE Healthcare
Koninklijke Philips N.V.
Canon Medical Systems
Fujifilm Holdings Corporation
Shanghai United Imaging Healthcare Co., LTD
Abbott
Terumo Corporation
Samsung Medison Co., Ltd.
Lepu Medical Technology
"The quality of research they have done for us has been excellent..."